A detailed history of Yousif Capital Management, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Yousif Capital Management, LLC holds 21,457 shares of CTLT stock, worth $1.36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,457
Previous 22,033 2.61%
Holding current value
$1.36 Million
Previous $1.24 Million 4.93%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$56.16 - $60.96 $32,348 - $35,112
-576 Reduced 2.61%
21,457 $1.3 Million
Q2 2024

Jul 31, 2024

SELL
$53.58 - $57.02 $38,791 - $41,282
-724 Reduced 3.18%
22,033 $1.24 Million
Q1 2024

Apr 26, 2024

SELL
$42.56 - $59.82 $44,943 - $63,169
-1,056 Reduced 4.43%
22,757 $1.28 Million
Q4 2023

Feb 01, 2024

SELL
$32.18 - $46.57 $8,141 - $11,782
-253 Reduced 1.05%
23,813 $1.07 Million
Q3 2023

Oct 30, 2023

SELL
$44.2 - $50.2 $53,968 - $61,294
-1,221 Reduced 4.83%
24,066 $1.1 Million
Q2 2023

Aug 02, 2023

BUY
$31.86 - $67.26 $79,490 - $167,813
2,495 Added 10.95%
25,287 $1.1 Million
Q1 2023

May 02, 2023

SELL
$45.44 - $74.26 $182,168 - $297,708
-4,009 Reduced 14.96%
22,792 $1.5 Million
Q4 2022

Jan 09, 2023

BUY
$41.39 - $81.0 $74,708 - $146,205
1,805 Added 7.22%
26,801 $0
Q3 2022

Nov 04, 2022

SELL
$72.36 - $113.1 $1,809 - $2,827
-25 Reduced 0.1%
24,996 $1.81 Million
Q2 2022

Aug 01, 2022

BUY
$87.2 - $114.05 $40,112 - $52,463
460 Added 1.87%
25,021 $2.69 Million
Q1 2022

May 12, 2022

BUY
$94.19 - $124.49 $44,269 - $58,510
470 Added 1.95%
24,561 $2.72 Million
Q4 2021

Jan 31, 2022

BUY
$119.57 - $139.07 $2.88 Million - $3.35 Million
24,091 New
24,091 $3.08 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.